Riskpilot← Back to searchSign inGet full accessFLUIMEDIX ApS
APSActiveCVR 27021689Dalgas Boulevard 4Engineering activities and related technical consultancy · NACE 7112Est. 20030 employeeswww.fluimedix.com
Revenue 2024
DKK -56K
-123% vs 2023
EBITDA margin
104.7%
-16% vs 2023
Equity ratio
73.5%
Financial strength
Net profit 2024
DKK -65K
+20% vs 2023
| Revenue | DKK -56K | -123% |
| EBITDA | DKK -59K | -16% |
| Net profit | DKK -65K | +20% |
| Total assets | DKK 324K | -52% |
| Equity | DKK 238K | -21% |
| Employees | 0 | — |
Legal name
FLUIMEDIX ApS
CVR number
27021689
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
6. februar 2003
Share capital
DKK 777.778
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af selskabets direktør og bestyrelsesformanden i forening.
Company purpose
Selskabets formål er at udvikle og kommercialisere teknologien bag den patenterede MEMSflowteknologi, der kan anvedes til at transportere væsker i kapillar-rør, samt anden dermed beslægtet virksomhed.
Address
Dalgas Boulevard 4
Phone
+4593949886
Email
write-us@fluimedix.com
Website
www.fluimedix.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -594 | -648 | -546 | -816 | -684 | -691 | -399 | -408 | -182 | -1 | -89 | 244 | -56 |
| Staff expenses | -1.619 | -1.441 | -1.749 | -1.865 | -2.198 | -2.007 | -2.307 | -769 | -73 | -292 | -299 | -295 | -3 |
| EBITDA | -2.213 | -2.089 | -2.295 | -2.681 | -2.882 | -2.698 | -2.706 | -1.177 | -254 | -293 | -389 | -51 | -59 |
| Depreciation & amort. | -7 | -8 | -13 | -13 | -14 | -17 | -17 | -61 | -71 | -60 | -71 | -60 | -16 |
| EBIT | -2.220 | -2.097 | -2.308 | -2.694 | -2.895 | -2.715 | -2.723 | -1.238 | -325 | -354 | -460 | -111 | -75 |
| Net financials | -7 | 9 | 7 | -486 | -1.844 | -2.206 | -5 | -3 | -1 | -2 | -4 | -0 | -6 |
| Profit before tax | -2.227 | -2.088 | -2.301 | -3.180 | -4.739 | -4.921 | -2.728 | -1.241 | -326 | -355 | -464 | -111 | -81 |
| Tax | -554 | -520 | -568 | -743 | -1.042 | -1.082 | -597 | -271 | -72 | -76 | -100 | -31 | -16 |
| Net profit | -1.674 | -1.568 | -1.733 | -2.437 | -3.697 | -3.839 | -2.132 | -970 | -254 | -279 | -364 | -81 | -65 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 879 | 4.224 | 2.575 | 4.678 | 4.813 | 3.122 | 1.992 | 716 | 1.151 | 793 | 445 | 674 | 324 |
| Equity | 533 | 3.965 | 2.232 | -205 | -3.902 | -7.739 | -6.350 | 680 | 1.026 | 747 | 383 | 303 | 238 |
| Long-term debt | 26 | 26 | 27 | 4.479 | 8.321 | 10.520 | 1 | 25 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 346 | 260 | 343 | 404 | 394 | 341 | 8.341 | 36 | 125 | 46 | 62 | 371 | 86 |
| Total debt | 346 | 260 | 343 | 4.882 | 8.715 | 10.861 | 8.341 | 36 | 125 | 46 | 62 | 371 | 86 |
EBITDA margin
-5898700.0%
This company
15.8%
Market median
-37333644% vs market
20122024
Equity ratio
73.5%
This company
38.2%
Market median
+92% vs market
20122024
Return on equity
-27.3%
This company
18.4%
Market median
-248% vs market
20122024
Net profit margin
-6490100.0%
This company
8.1%
Market median
-80124791% vs market
20122024
Asset turnover
-0.17×
This company
1.12×
Market median
-115% vs market
20122024
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TU Management | Management | 2003 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2013 | — | — | |
| Chairman | 2010 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2003 | — | — | |
| Chairman | 2003 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2010 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
OPFINDER HOLDING AF 2003 ApS | Company | 100.0% | 100.0% | 2019 |
BAUNEGÅRD ApS | Company | 66.7% | 66.7% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OPFINDER HOLDING AF 2003 ApS
FLUIMEDIX ApS Board members of FLUIMEDIX ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tomas Ussing | Management | 0 companies |
| Tom Olesen | Board of Directors | 0 companies |
| Rolf Singer | Board of Directors | 0 companies |
| Tonni Bülow-Nielsen | Board of Directors | 0 companies |
| Ole Bitsch-Jensen | Chairman | 0 companies |
| Sissel Mygind Trap | Board of Directors | 0 companies |
| Niels Meidahl | Board of Directors | 0 companies |
| Mikael Ørum | Chairman | 0 companies |
| Richard Gustav Bunck | Chairman | 0 companies |
| Rolf Bertil Ehrnström | Board of Directors | 0 companies |
| Steen Hansen | Board of Directors | 0 companies |
| Per Ove Öhman | Board of Directors | 0 companies |